Dr David L Hava
Chief Scientific Officer

Is this your profile?

About

David L Hava was Chief Scientific Officer at Pulmatrix.

Contributions

ADVANCES IN PULMONARY DELIVERY OF INHALED ANTI-INFECTIVES

With the growing problems caused by antimicrobial resistance, there is increasing interest in the use of improved strategies for drug delivery. David L. Hava explores the benefits of nebulised inhaled antibiotics delivered via high throughput nebulisers for aqueous formulations or dry powder inhalations for cystic fibrosis patients.

Top

W3 Total Cache is currently running in Pro version Development mode.